Vaccine therapy for advanced breast cancer
Part of Cancer, Skin clinical trials.
This trial tests an investigational vaccine called ConvitVax for people with advanced or metastatic breast cancer that has not responded to standard treatments. The vaccine is designed to help your immune system fight the cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman aged 18 or older.
- You have been diagnosed with breast cancer (adenocarcinoma) that has spread or cannot be removed by surgery, and you have tried standard treatments or are not eligible for them.
- Your cancer can be measured on scans (at least 1 cm in size).
- You have a small reaction (less than 10 mm) to a skin test for tuberculosis (PPD).
- You are not pregnant, breastfeeding, or planning to become pregnant, and you agree to use effective birth control if you could become pregnant.
- You are willing to sign consent forms and follow the study procedures.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a vaccine that targets HER2 protein on cancer cells. It is for people with advanced breast or esophageal cancer whose tumors have certain markers. The vaccine may help your immune system fight the cancer.
This trial tests a personalized vaccine made from your own immune cells to help your body fight advanced breast cancer. It's for people with a specific genetic marker and whose cancer has not responded to standard treatments.
This trial tests a vaccine (STEMVAC) given with your standard hormone therapy or chemotherapy. It is for people with advanced hormone receptor-positive, HER2-negative breast cancer who are already on certain treatments. The goal is to see if adding the vaccine can help control the cancer better.
This Phase 2 trial tests whether adding a personalized cancer vaccine to durvalumab (an immunotherapy), tremelimumab (another immunotherapy), and chemotherapy can improve outcomes for people with metastatic triple-negative breast cancer. It may help your immune system recognize your specific tumor features.
This trial tests a vaccine (MV-s-NAP) that is injected directly into a tumor to stimulate your immune system against breast cancer. It is for people with metastatic breast cancer that has spread despite prior treatments.
This trial tests a cancer vaccine called STEMVAC combined with chemotherapy in people with a type of breast cancer that has spread and does not have certain markers. The goal is to see if adding the vaccine helps the chemotherapy work better.
Hear when a new Metastatic Breast Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.